PubMed:10090931
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 54-116 | cell_line | denotes | retinoic acid-resistant acute promyelocytic leukemia cell line |
| T2 | 118-122 | cell_line | denotes | UF-1 |
| T3 | 154-168 | protein | denotes | p21(WAF1/CIP1) |
| T4 | 173-182 | protein | denotes | p27(KIP1) |
| T5 | 388-397 | cell_type | denotes | APL cells |
| T6 | 485-508 | protein | denotes | transcriptional factors |
| T7 | 510-522 | protein | denotes | RA receptors |
| T8 | 524-528 | protein | denotes | RARs |
| T9 | 534-554 | protein | denotes | retinoid X receptors |
| T10 | 556-560 | protein | denotes | RXRs |
| T11 | 563-567 | protein | denotes | RXRs |
| T12 | 588-636 | protein | denotes | 1, 25-dihydroxyvitamin D3 [1,25(OH)2D3] receptor |
| T13 | 638-641 | protein | denotes | VDR |
| T14 | 701-740 | protein | denotes | cyclin-dependent kinase (cdk) inhibitor |
| T15 | 741-755 | protein | denotes | p21(WAF1/CIP1) |
| T16 | 762-791 | DNA | denotes | vitamin D3-responsive element |
| T17 | 793-797 | DNA | denotes | VDRE |
| T18 | 806-814 | DNA | denotes | promoter |
| T19 | 859-873 | protein | denotes | p21(WAF1/CIP1) |
| T20 | 914-941 | cell_line | denotes | myeloid leukemic cell lines |
| T21 | 980-993 | cell_line | denotes | APL cell line |
| T22 | 995-999 | cell_line | denotes | UF-1 |
| T23 | 1091-1101 | cell_line | denotes | UF-1 cells |
| T24 | 1154-1166 | cell_type | denotes | granulocytes |
| T25 | 1426-1440 | protein | denotes | p21(WAF1/CIP1) |
| T26 | 1445-1459 | RNA | denotes | p27(KIP1) mRNA |
| T27 | 1533-1566 | RNA | denotes | p21(WAF1/CIP1) and p27(KIP1) mRNA |
| T28 | 1640-1654 | protein | denotes | p21(WAF1/CIP1) |
| T29 | 1659-1668 | protein | denotes | p27(KIP1) |
| T30 | 1820-1834 | protein | denotes | p21(WAF1/CIP1) |
| T31 | 1939-1948 | protein | denotes | p27(KIP1) |
| T32 | 1996-2006 | cell_line | denotes | UF-1 cells |
| T33 | 2094-2103 | protein | denotes | p27(KIP1) |
| T34 | 2205-2214 | protein | denotes | p27(KIP1) |
| T35 | 2251-2264 | protein | denotes | CD11b antigen |
| T36 | 2268-2290 | cell_type | denotes | myeloid leukemic cells |
| T37 | 2338-2348 | cell_line | denotes | UF-1 cells |
| T38 | 2395-2409 | protein | denotes | p21(WAF1/CIP1) |
| T39 | 2414-2423 | protein | denotes | p27(KIP1) |
| T40 | 2558-2572 | protein | denotes | cdk inhibitors |
| T41 | 2666-2676 | cell_line | denotes | UF-1 cells |
| T42 | 2691-2703 | cell_type | denotes | granulocytes |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 10090931-0#163#167#gene1026 | 163-167 | gene1026 | denotes | CIP1 |
| 10090931-0#163#167#gene56996 | 163-167 | gene56996 | denotes | CIP1 |
| 10090931-0#177#181#gene1027 | 177-181 | gene1027 | denotes | KIP1 |
| 10090931-0#177#181#gene10519 | 177-181 | gene10519 | denotes | KIP1 |
| 10090931-0#158#162#gene1026 | 158-162 | gene1026 | denotes | WAF1 |
| 10090931-0#78#106#diseaseC0023487 | 78-106 | diseaseC0023487 | denotes | acute promyelocytic leukemia |
| 163#167#gene102678#106#diseaseC0023487 | 10090931-0#163#167#gene1026 | 10090931-0#78#106#diseaseC0023487 | associated_with | CIP1,acute promyelocytic leukemia |
| 163#167#gene5699678#106#diseaseC0023487 | 10090931-0#163#167#gene56996 | 10090931-0#78#106#diseaseC0023487 | associated_with | CIP1,acute promyelocytic leukemia |
| 177#181#gene102778#106#diseaseC0023487 | 10090931-0#177#181#gene1027 | 10090931-0#78#106#diseaseC0023487 | associated_with | KIP1,acute promyelocytic leukemia |
| 177#181#gene1051978#106#diseaseC0023487 | 10090931-0#177#181#gene10519 | 10090931-0#78#106#diseaseC0023487 | associated_with | KIP1,acute promyelocytic leukemia |
| 158#162#gene102678#106#diseaseC0023487 | 10090931-0#158#162#gene1026 | 10090931-0#78#106#diseaseC0023487 | associated_with | WAF1,acute promyelocytic leukemia |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-24 | NP | denotes | 1,25-Dihydroxyvitamin D3 |
| C2 | 154-168 | NP | denotes | p21(WAF1/CIP1) |
| C3 | 184-213 | NP | denotes | Retinoic acid (RA) resistance |
| C4 | 239-287 | NP | denotes | patients with acute promyelocytic leukemia (APL) |
| C5 | 288-291 | NP | denotes | who |
| C6 | 306-318 | NP | denotes | all-trans RA |
| C7 | 371-384 | NP | denotes | RA resistance |
| C8 | 441-443 | NP | denotes | RA |
| C9 | 460-508 | NP | denotes | two distinct families of transcriptional factors |
| C11 | 534-561 | NP | denotes | retinoid X receptors (RXRs) |
| C10 | 510-561 | NP | denotes | RA receptors (RARs) and retinoid X receptors (RXRs) |
| C12 | 563-567 | NP | denotes | RXRs |
| C13 | 653-658 | NP | denotes | their |
| C14 | 697-755 | NP | denotes | The cyclin-dependent kinase (cdk) inhibitor p21(WAF1/CIP1) |
| C15 | 802-805 | NP | denotes | its |
| C16 | 820-831 | NP | denotes | 1,25(OH)2D3 |
| C17 | 859-873 | NP | denotes | p21(WAF1/CIP1) |
| C18 | 1018-1031 | NP | denotes | RA resistance |
| C19 | 1033-1044 | NP | denotes | 1,25(OH)2D3 |
| C20 | 1091-1101 | NP | denotes | UF-1 cells |
| C21 | 1135-1146 | NP | denotes | these cells |
| C22 | 1219-1231 | NP | denotes | all-trans RA |
| C23 | 1298-1300 | NP | denotes | RA |
| C24 | 1426-1471 | NP | denotes | p21(WAF1/CIP1) and p27(KIP1) mRNA and protein |
| C25 | 1485-1496 | NP | denotes | these cells |
| C26 | 1498-1520 | NP | denotes | Northern blot analysis |
| C27 | 1533-1578 | NP | denotes | p21(WAF1/CIP1) and p27(KIP1) mRNA and protein |
| C28 | 1592-1603 | NP | denotes | these cells |
| C29 | 1605-1627 | NP | denotes | Northern blot analysis |
| C30 | 1721-1732 | NP | denotes | 1,25(OH)2D3 |
| C31 | 1996-2006 | NP | denotes | UF-1 cells |
| C32 | 2042-2054 | NP | denotes | 1, 25(OH)2D3 |
| C33 | 2059-2061 | NP | denotes | RA |
| C34 | 2162-2180 | NP | denotes | 1, 25(OH)2D3 alone |
| C35 | 2305-2313 | NP | denotes | RA alone |
| C36 | 2338-2349 | NP | denotes | UF-1 cells; |
| C37 | 2359-2361 | NP | denotes | it |
| C38 | 2514-2525 | NP | denotes | 1,25(OH)2D3 |
| C39 | 2534-2572 | NP | denotes | increased expression of cdk inhibitors |
| C40 | 2574-2579 | NP | denotes | which |
| R1 | C5 | C4 | coref-relat | who,patients with acute promyelocytic leukemia (APL) |
| R2 | C7 | C3 | coref-ident | RA resistance,Retinoic acid (RA) resistance |
| R3 | C10 | C9 | coref-appos | RA receptors (RARs) and retinoid X receptors (RXRs),two distinct families of transcriptional factors |
| R4 | C12 | C11 | coref-ident | RXRs,retinoid X receptors (RXRs) |
| R5 | C13 | C12 | coref-pron | their,RXRs |
| R6 | C14 | C2 | coref-ident | The cyclin-dependent kinase (cdk) inhibitor p21(WAF1/CIP1),p21(WAF1/CIP1) |
| R7 | C15 | C14 | coref-pron | its,The cyclin-dependent kinase (cdk) inhibitor p21(WAF1/CIP1) |
| R8 | C16 | C1 | coref-ident | "1,25(OH)2D3","1,25-Dihydroxyvitamin D3" |
| R9 | C17 | C14 | coref-ident | p21(WAF1/CIP1),The cyclin-dependent kinase (cdk) inhibitor p21(WAF1/CIP1) |
| R10 | C18 | C7 | coref-ident | RA resistance,RA resistance |
| R11 | C19 | C16 | coref-ident | "1,25(OH)2D3","1,25(OH)2D3" |
| R12 | C21 | C20 | coref-ident | these cells,UF-1 cells |
| R13 | C22 | C6 | coref-ident | all-trans RA,all-trans RA |
| R14 | C23 | C8 | coref-ident | RA,RA |
| R15 | C25 | C21 | coref-ident | these cells,these cells |
| R16 | C27 | C24 | coref-ident | p21(WAF1/CIP1) and p27(KIP1) mRNA and protein,p21(WAF1/CIP1) and p27(KIP1) mRNA and protein |
| R17 | C28 | C25 | coref-ident | these cells,these cells |
| R18 | C29 | C26 | coref-ident | Northern blot analysis,Northern blot analysis |
| R19 | C30 | C19 | coref-ident | "1,25(OH)2D3","1,25(OH)2D3" |
| R20 | C31 | C28 | coref-ident | UF-1 cells,these cells |
| R21 | C32 | C30 | coref-ident | "1, 25(OH)2D3","1,25(OH)2D3" |
| R22 | C33 | C23 | coref-ident | RA,RA |
| R23 | C34 | C32 | coref-ident | "1, 25(OH)2D3 alone","1, 25(OH)2D3" |
| R24 | C35 | C33 | coref-ident | RA alone,RA |
| R25 | C36 | C31 | coref-ident | UF-1 cells;,UF-1 cells |
| R26 | C37 | C35 | coref-pron | it,RA alone |
| R27 | C38 | C34 | coref-ident | "1,25(OH)2D3","1, 25(OH)2D3 alone" |
| R28 | C40 | C39 | coref-relat | which,increased expression of cdk inhibitors |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-183 | Sentence | denotes | 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). |
| S2 | 184-319 | Sentence | denotes | Retinoic acid (RA) resistance is a serious problem for patients with acute promyelocytic leukemia (APL) who are receiving all-trans RA. |
| S3 | 320-416 | Sentence | denotes | However, the mechanisms and strategies to overcome RA resistance by APL cells are still unclear. |
| S4 | 417-562 | Sentence | denotes | The biologic effects of RA are mediated by two distinct families of transcriptional factors: RA receptors (RARs) and retinoid X receptors (RXRs). |
| S5 | 563-696 | Sentence | denotes | RXRs heterodimerize with 1, 25-dihydroxyvitamin D3 [1,25(OH)2D3] receptor (VDR), enabling their efficient transcriptional activation. |
| S6 | 697-942 | Sentence | denotes | The cyclin-dependent kinase (cdk) inhibitor p21(WAF1/CIP1) has a vitamin D3-responsive element (VDRE) in its promoter, and 1,25(OH)2D3 enhances the expression of p21(WAF1/CIP1) and induces differentiation of selected myeloid leukemic cell lines. |
| S7 | 943-1032 | Sentence | denotes | We have recently established a novel APL cell line (UF-1) with features of RA resistance. |
| S8 | 1033-1167 | Sentence | denotes | 1,25(OH)2D3 can induce growth inhibition and G1 arrest of UF-1 cells, resulting in differentiation of these cells toward granulocytes. |
| S9 | 1168-1232 | Sentence | denotes | This 1, 25(OH)2D3-induced G1 arrest is enhanced by all-trans RA. |
| S10 | 1233-1379 | Sentence | denotes | Also, 1, 25(OH)2D3 (10(-10) to 10(-7) mol/L) in combination with RA markedly inhibits cellular proliferation in a dose- and time-dependent manner. |
| S11 | 1380-1497 | Sentence | denotes | Associated with these findings, the levels of p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells. |
| S12 | 1498-1604 | Sentence | denotes | Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells. |
| S13 | 1605-1782 | Sentence | denotes | Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) transcripts were induced after 6 hours' exposure to 1,25(OH)2D3 and then decreased to basal levels over 48 hours. |
| S14 | 1783-2007 | Sentence | denotes | Western blot experiments showed that p21(WAF1/CIP1) protein levels increased and became detectable after 12 hours of 1,25(OH)2D3 treatment and induction of p27(KIP1) protein was much more gradual and sustained in UF-1 cells. |
| S15 | 2008-2181 | Sentence | denotes | Interestingly, the combination of 1, 25(OH)2D3 and RA markedly enhanced the levels of p27(KIP1) transcript and protein as compared with levels induced by 1, 25(OH)2D3 alone. |
| S16 | 2182-2291 | Sentence | denotes | In addition, exogenous p27(KIP1) expression can enhance the level of CD11b antigen in myeloid leukemic cells. |
| S17 | 2292-2480 | Sentence | denotes | In contrast, RA alone can induce G1 arrest of UF-1 cells; however, it did not result in an increase of p21(WAF1/CIP1) and p27(KIP1) transcript and protein expression in RA-resistant cells. |
| S18 | 2481-2704 | Sentence | denotes | Taken together, we conclude that 1,25(OH)2D3 induces increased expression of cdk inhibitors, which mediates a G1 arrest, and this may be associated with differentiation of RA-resistant UF-1 cells toward mature granulocytes. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-24 | lipid | denotes | 1,25-Dihydroxyvitamin D3 |
| T2 | 54-67 | other_organic_compound | denotes | retinoic acid |
| T3 | 118-122 | cell_line | denotes | UF-1 |
| T4 | 154-168 | protein_molecule | denotes | p21(WAF1/CIP1) |
| T5 | 173-182 | protein_molecule | denotes | p27(KIP1) |
| T6 | 184-197 | other_organic_compound | denotes | Retinoic acid |
| T7 | 239-247 | multi_cell | denotes | patients |
| T8 | 253-281 | other_name | denotes | acute promyelocytic leukemia |
| T9 | 283-286 | other_name | denotes | APL |
| T10 | 306-318 | other_organic_compound | denotes | all-trans RA |
| T11 | 371-373 | other_organic_compound | denotes | RA |
| T12 | 388-391 | other_name | denotes | APL |
| T13 | 441-443 | other_organic_compound | denotes | RA |
| T14 | 485-508 | protein_family_or_group | denotes | transcriptional factors |
| T15 | 510-512 | other_organic_compound | denotes | RA |
| T16 | 524-528 | protein_family_or_group | denotes | RARs |
| T17 | 534-554 | protein_family_or_group | denotes | retinoid X receptors |
| T18 | 556-560 | protein_family_or_group | denotes | RXRs |
| T19 | 563-567 | protein_family_or_group | denotes | RXRs |
| T20 | 588-613 | lipid | denotes | 1, 25-dihydroxyvitamin D3 |
| T21 | 615-626 | lipid | denotes | 1,25(OH)2D3 |
| T22 | 638-641 | protein_family_or_group | denotes | VDR |
| T23 | 669-695 | other_name | denotes | transcriptional activation |
| T24 | 701-724 | protein_family_or_group | denotes | cyclin-dependent kinase |
| T25 | 726-729 | protein_family_or_group | denotes | cdk |
| T26 | 741-755 | protein_molecule | denotes | p21(WAF1/CIP1) |
| T27 | 762-791 | DNA_domain_or_region | denotes | vitamin D3-responsive element |
| T28 | 793-797 | DNA_domain_or_region | denotes | VDRE |
| T29 | 806-814 | DNA_domain_or_region | denotes | promoter |
| T30 | 820-831 | lipid | denotes | 1,25(OH)2D3 |
| T31 | 859-873 | protein_molecule | denotes | p21(WAF1/CIP1) |
| T32 | 914-941 | cell_line | denotes | myeloid leukemic cell lines |
| T33 | 980-983 | other_name | denotes | APL |
| T34 | 995-999 | cell_line | denotes | UF-1 |
| T35 | 1018-1020 | other_organic_compound | denotes | RA |
| T36 | 1033-1044 | lipid | denotes | 1,25(OH)2D3 |
| T37 | 1078-1087 | other_name | denotes | G1 arrest |
| T38 | 1091-1101 | cell_line | denotes | UF-1 cells |
| T39 | 1154-1166 | cell_type | denotes | granulocytes |
| T40 | 1173-1185 | lipid | denotes | 1, 25(OH)2D3 |
| T41 | 1194-1203 | other_name | denotes | G1 arrest |
| T42 | 1229-1231 | other_organic_compound | denotes | RA |
| T43 | 1239-1251 | lipid | denotes | 1, 25(OH)2D3 |
| T44 | 1298-1300 | other_organic_compound | denotes | RA |
| T45 | 1319-1341 | other_name | denotes | cellular proliferation |
| T46 | 1426-1440 | protein_molecule | denotes | p21(WAF1/CIP1) |
| T47 | 1445-1454 | protein_molecule | denotes | p27(KIP1) |
| T48 | 1605-1627 | other_name | denotes | Northern blot analysis |
| T49 | 1640-1654 | protein_molecule | denotes | p21(WAF1/CIP1) |
| T50 | 1659-1668 | protein_molecule | denotes | p27(KIP1) |
| T51 | 1721-1732 | lipid | denotes | 1,25(OH)2D3 |
| T52 | 1783-1807 | other_name | denotes | Western blot experiments |
| T53 | 1820-1834 | protein_molecule | denotes | p21(WAF1/CIP1) |
| T54 | 1900-1911 | lipid | denotes | 1,25(OH)2D3 |
| T55 | 1939-1948 | protein_molecule | denotes | p27(KIP1) |
| T56 | 1996-2006 | cell_line | denotes | UF-1 cells |
| T57 | 2042-2054 | lipid | denotes | 1, 25(OH)2D3 |
| T58 | 2059-2061 | other_organic_compound | denotes | RA |
| T59 | 2094-2103 | protein_molecule | denotes | p27(KIP1) |
| T60 | 2162-2174 | lipid | denotes | 1, 25(OH)2D3 |
| T61 | 2205-2214 | protein_molecule | denotes | p27(KIP1) |
| T62 | 2251-2264 | protein_molecule | denotes | CD11b antigen |
| T63 | 2268-2290 | cell_type | denotes | myeloid leukemic cells |
| T64 | 2305-2307 | other_organic_compound | denotes | RA |
| T65 | 2325-2334 | other_name | denotes | G1 arrest |
| T66 | 2338-2348 | cell_line | denotes | UF-1 cells |
| T67 | 2395-2409 | protein_molecule | denotes | p21(WAF1/CIP1) |
| T68 | 2414-2423 | protein_molecule | denotes | p27(KIP1) |
| T69 | 2461-2463 | other_organic_compound | denotes | RA |
| T70 | 2514-2525 | lipid | denotes | 1,25(OH)2D3 |
| T71 | 2558-2561 | protein_family_or_group | denotes | cdk |
| T72 | 2591-2600 | other_name | denotes | G1 arrest |
| T73 | 2653-2655 | other_organic_compound | denotes | RA |
| T74 | 2666-2676 | cell_line | denotes | UF-1 cells |
| T75 | 2691-2703 | cell_type | denotes | granulocytes |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 158-162 | gene:1026 | denotes | WAF1 |
| T1 | 78-106 | disease:C0023487 | denotes | acute promyelocytic leukemia |
| T2 | 163-167 | gene:1026 | denotes | CIP1 |
| T3 | 78-106 | disease:C0023487 | denotes | acute promyelocytic leukemia |
| T4 | 163-167 | gene:56996 | denotes | CIP1 |
| T5 | 78-106 | disease:C0023487 | denotes | acute promyelocytic leukemia |
| T6 | 177-181 | gene:1027 | denotes | KIP1 |
| T7 | 78-106 | disease:C0023487 | denotes | acute promyelocytic leukemia |
| T8 | 177-181 | gene:10519 | denotes | KIP1 |
| T9 | 78-106 | disease:C0023487 | denotes | acute promyelocytic leukemia |
| R1 | T0 | T1 | associated_with | WAF1,acute promyelocytic leukemia |
| R2 | T2 | T3 | associated_with | CIP1,acute promyelocytic leukemia |
| R3 | T4 | T5 | associated_with | CIP1,acute promyelocytic leukemia |
| R4 | T6 | T7 | associated_with | KIP1,acute promyelocytic leukemia |
| R5 | T8 | T9 | associated_with | KIP1,acute promyelocytic leukemia |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 253-281 | HP_0004836 | denotes | acute promyelocytic leukemia |
| T2 | 273-281 | HP_0001909 | denotes | leukemia |